# A Clinical Study for the Efficacy and Safety of BL0020 Injection in Patients With Small Cell Lung Cancer Transformed From Non-Small Cell Lung Cancer Following E

Source: https://onco.cc/trials/nct07414927/  
OnCo record `nct07414927` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 1/2 trial in lung cancer, run by Shanghai Best-Link Bioscience, LLC, not yet recruiting.

## Summary

A Clinical Study for the Efficacy and Safety of BL0020 Injection in Patients With Small Cell Lung Cancer Transformed From Non-Small Cell Lung Cancer Following EGFR TKI Therapy is a phase 1/2, interventional study registered as NCT07414927 by Shanghai Best-Link Bioscience, LLC, with a registry enrolment figure of 48 participants, started 2026-03-27 and due to reach its primary completion in 2027-12-22. Interventions recorded: BL0020. Conditions listed: Small Cell Carcinoma of Lung. Primary outcome: Objective response rate (ORR). Lung eligibility wording from the registry: "Patients with initial diagnosis of EGFR-mutated NSCLC and histologically or cytologically confirmed transformation to SCLC following treatment with EGFR tyrosine kinase inhibitor". Sites: China. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: planned
- Last checked: 2026-09-25
- Tags: ctgov-ingest; lung-deep-dive
- Registry id: NCT07414927
- Phase: 1/2
- Setting: An Open-Label, Single-Arm Phase I/II Clinical Study to Evaluate the Efficacy and Safety of BL0020 Injection in Patients With Small Cell Lung Cancer Transformed From Non-Small Cell Lung Cancer Following EGFR TKI Therapy
- Sponsor: Shanghai Best-Link Bioscience, LLC
- Enrolled: 48

## Sources

- ClinicalTrials.gov NCT07414927: https://clinicaltrials.gov/study/NCT07414927

## Connected records

- cancers: [EGFR-mutated non-small-cell lung cancer](https://onco.cc/cancers/egfr-mutant-nsclc/), [Small-cell lung cancer](https://onco.cc/cancers/sclc/)
- terms: [Lung cancer trials open today (registry snapshot)](https://onco.cc/terms/lung-trials-open-today/)

---
JSON: https://onco.cc/api/v1/entities/nct07414927.json